Additional Insights on Metabolically Healthy Obesity Among Pediatric Populations
By
Taotao Zheng
Yan He
Ke Pan
September 1, 2026
Clinical Scorecard: Additional Insights on Metabolically Healthy Obesity Among Pediatric Populations
At a Glance
Category Detail
Condition Metabolically Healthy Obesity (MHO) Key Mechanisms Cumulative type 2 diabetes incidence and psychosocial impacts of treatment Target Population Children aged 7 to 8.9 years Care Setting Pediatric obesity treatment
Key Highlights
Cumulative type 2 diabetes incidence by age 30 years was 9.1% in the MHO group. Type 2 diabetes incidence was 36.2 per 10,000 person-years among children with MHO. MHO prevalence was 59.6% among children aged 7 to 8.9 years. The study lacked an untreated comparator group with MHO. Psychosocial harms associated with weight loss interventions were not analyzed. Guideline-Based Recommendations
Diagnosis
Identify children with obesity and assess metabolic health status. Management
Consider the potential harms of treatment in metabolically healthy individuals. Monitoring & Follow-up
Monitor for transitions from MHO to metabolically unhealthy obesity. Risks
Unnecessary medicalization may lead to psychological harm and stigma. Patient & Prescribing Data
Children with obesity, particularly those classified as MHO.
Weight loss interventions may reinforce stigma and cause disordered eating behaviors.
Clinical Best Practices
Conduct rigorous benefit-harm assessments before initiating treatment. Incorporate psychological costs of treatment nonresponse and weight cycling in evaluations. Related Resources & Content
